MAPK14 and lip and oral cavity carcinoma: Using a p38 inhibitor, SB203580, we confirmed that luteolin-7-O-glucoside reduces oral cancer cell migration by altering p38-induced activation of MMP-2 (Figure 6, Figure 7, and Figure 8).